Am Fam Physician. 2019 Jan 15;99(2):77.
Vitamin K Antagonists. The Practice Guideline, “Newly Detected Atrial Fibrillation: AAFP Updates Guidelines on Pharmacologic Management” (September 1, 2017, p. 332), incorrectly identified vitamin K antagonists as vitamin K agonists in the first paragraph in the left column on page 333. The sentence should have read: “Vitamin K antagonists are the first-line option, with high-quality data indicating that they have a lower stroke risk and all-cause mortality vs. placebo.” The online version of the article has been corrected.
Copyright © 2019 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions